Preoperative Analgesia: The Effectiveness of the PENG Block in Patients With Hip Fractures

Preoperative Analgesia: The Effect of the Pericapsular Nerve Group (PENG) Block Administered Preoperatively in Patients With Hip Fractures on Preoperative Analgesic Efficacy, Early Postoperative Discharge, Mortality, and Morbidity.

Status

Not yet recruiting

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07003633

Enrollment

Registered

2025-06-04

Start date

2025-06-01

Completion date

2026-06-01

Last updated

2025-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Fracture Surgeries

Keywords

Analgesia, PENG block, Hip Fracture

Brief summary

The aim is to provide effective preoperative analgesia in patients undergoing surgical procedures due to hip fractures by administering a pericapsular nerve group (PENG) block under ultrasound guidance. This approach seeks to increase patient satisfaction, reduce analgesic requirements, enable earlier discharge, and decrease morbidity and mortality.

Interventions

PROCEDUREPENG block with 0.25% bupivacaine guided by ultrasound.

PENG (Pericapsular nerve block) is a peripheral nerve block which is performed for patients with hip fractures aimed to prevent preoperative and postoperative pain. It is performed under sterile conditions under ultrasound guideance.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

SINGLE (Subject)

Masking description

The patients will be randomized to their rescpective groups with closed envelope method.

Eligibility

Sex/Gender

ALL

Age

45 Years to 95 Years

Healthy volunteers

Inclusion criteria

* Patients undergoing hip farcture surgery

Exclusion criteria

* Chronic analgesics consumption * Patients contraindicated for neuraxial anesthesia * Alcohol and drug addiction * Allergies to local anesthetics and opioids * Patients who refuses to participate in the study

Design outcomes

Primary

Measure	Time frame	Description
Preoperative Pain Scores and Opioid Consumption	24 hours preoperatively	Preoperative pain of patients will be assessed with NRS (Numeric Raitng Scale) which ranges from 0 (no pain) to 10 (the most severe pain imaginable).

Secondary

Measure	Time frame	Description
Discharge Time	From surgery to discharge up to 30 days	—
Postoperative Mortality and Morbidity	30 days after surgery	Postoperative complications such as infections, embolism, chronic pain and survival status
Opioid Consumption	24 hours preoperatively	Opioid consumption will be assessed with patient controlled analgesia (PCA) device which measures analgesic drug consumption. Fentanyl consumption unit will be micrograms.

Countries

Turkey (Türkiye)

Contacts

Primary ContactAlim Miniksar, M.D.

alimminiksar@gmail.com+905069499002

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026